Pneumologisches Studienzentrum MVZ dieLungenaerzte
- Address
- Bergmannstraße 5-7, 10961 Berlin, Germany
Pneumologisches Studienzentrum MVZ dieLungenaerzte - Chronic Cough Research Center
Pneumologisches Studienzentrum MVZ dieLungenaerzte is a specialized pulmonology research center dedicated to advancing treatment options for challenging respiratory conditions. The center focuses on conducting pivotal clinical trials for patients suffering from difficult-to-treat pulmonary disorders, with particular expertise in chronic cough syndromes that significantly impact patient quality of life.
- Refractory chronic cough treatment and novel therapeutic interventions
- Unexplained chronic cough diagnosis and management
- Phase 3 efficacy and safety studies in respiratory medicine
The research team specializes in evaluating innovative pharmacological approaches for refractory chronic cough, including cases where traditional treatments have failed and causes remain unexplained. Through comprehensive 24-hour cough frequency monitoring and long-term safety assessments, the center contributes to the development of breakthrough therapies that address unmet medical needs in adult patients with persistent respiratory symptoms. Their expertise in managing complex pulmonary cases positions them as a key site for advanced clinical investigations in chronic cough disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pneumologisches Studienzentrum MVZ dieLungenaerzte
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicentre, Parallel-group, Phase IIb, Randomised, Double blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO). | AstraZeneca AB | Phase II | Recruiting | Sep 2025 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Budesonide | 3 | Unknown | 2022-03-23 | 2024-07-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.